TY - JOUR AU - Hu, Che-Ming Jack AU - Chien, Chu-Yang AU - Liu, Ming-Tsan AU - Fang, Zih-Syun AU - Chang, Sui-Yuan AU - Juang, Rong-Huay AU - Chang, Shih-Chung AU - Chen, Hui-Wen PY - 2017 DA - 2017/01/07 TI - Multi-antigen avian influenza a (H7N9) virus-like particles: particulate characterizations and immunogenicity evaluation in murine and avian models JO - BMC Biotechnology SP - 2 VL - 17 IS - 1 AB - Human infection with avian influenza A virus (H7N9) was first reported in China in March 2013. Since then, hundreds of cases have been confirmed showing severe symptoms with a high mortality rate. The virus was transmitted from avian species to humans and has spread to many neighboring areas, raising serious concerns over its pandemic potential. Towards containing the disease, the goal of this study is to prepare a virus-like particle (VLP) that consists of hemagglutinin (HA), neuraminidase (NA) and matrix protein 1 (M1) derived from the human isolate A/Taiwan/S02076/2013(H7N9) for potential vaccine development. SN - 1472-6750 UR - https://doi.org/10.1186/s12896-016-0321-6 DO - 10.1186/s12896-016-0321-6 ID - Hu2017 ER -